10.27.2018 Issue 145

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Associate Director/Director, Medical Affairs - HEOR

The incumbent is an experienced, well organized professional who will develop, implement and manage health economics and outcomes research (HEOR) strategies and tactics to demonstrate the value of pipeline and inline products in multiple therapeutic areas.

Health Economics and Outcomes Associate Consultant

Research Data Assistant or Research Data Coordinator-PS8373

Research Associate III- Patient-Centered Research- Hammersmith

Healthcare Software Product Manager

Health Economist

Lead Health Economist

Associate Director Health Economics

Watson Health - Outcomes Research Leader (HEOR)

Senior Director, HEOR Oncology and Specialty

ICER Mulls Biopharma Evaluation Program

Executives Talk Blockchain, EMR with Value and Outcomes

Quinn Looks at CMS’ Justification of Authority for Drug Prices in Ads

Partnership of Hospitals Targets High Drug Prices

Industry Spotlight

Conferences Webinars
    October 28-30, Orlando, Florida

12th Partnering With ACOs and IDNs Summit
    October 29-30, Los Angeles, California

HERG Short Course on Economic Evaluation in Health Care
    November 7-9, Middlesex, U.K.

10th Annual Federal Pricing and Reporting Summit
    November 7-8, Baltimore, Maryland

How to Use the Immunization Delivery Cost Catalogue
    October 30

Key Considerations for Payers Moving to the Cloud
    October 30

Levers of Human Deception: The Science and Methodology Behind Social Engineering
    November 6

2-Part Informational Webinar: Online MS Degree, Pharmaceutical Outcomes and Policy
    November 13

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Health Care USA: A Cancer on the American Dream

The Utility of ICER Reports for Private Payer Drug Coverage Decision-Making: Cost-Effectiveness Assessments

Advancing Biosimilar Sustainability in Europe

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON    Truven